Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer

BACKGROUND/AIMS: The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating meta-static pancreatic cancer (MPC). We aimed to evaluate the therapeutic outcomes and prognostic role of treatment-related peripheral neuropathy in patients with MPC treated with nab-P/Gem in...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Min Su, Ryu, Ji Kon, Choi, Young Hoon, Choi, Jin Ho, Huh, Gunn, Paik, Woo Hyun, Lee, Sang Hyub, Kim, Yong-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254624/
https://www.ncbi.nlm.nih.gov/pubmed/30400731
http://dx.doi.org/10.5009/gnl18220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254624/
https://www.ncbi.nlm.nih.gov/pubmed/30400731
http://dx.doi.org/10.5009/gnl18220

Ejemplares similares